Treace Medical Concepts Statistics
Total Valuation
TMCI has a market cap or net worth of $494.64 million. The enterprise value is $484.45 million.
Important Dates
The last earnings date was Tuesday, November 5, 2024, after market close.
Earnings Date | Nov 5, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TMCI has 62.30 million shares outstanding. The number of shares has increased by 4.46% in one year.
Current Share Class | 62.30M |
Shares Outstanding | 62.30M |
Shares Change (YoY) | +4.46% |
Shares Change (QoQ) | +0.24% |
Owned by Insiders (%) | 26.70% |
Owned by Institutions (%) | 54.04% |
Float | 45.66M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.44 |
Forward PS | 2.22 |
PB Ratio | 4.74 |
P/TBV Ratio | 5.93 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2.39 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.12, with a Debt / Equity ratio of 0.67.
Current Ratio | 4.12 |
Quick Ratio | 2.81 |
Debt / Equity | 0.67 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -11.84 |
Financial Efficiency
Return on equity (ROE) is -50.69% and return on invested capital (ROIC) is -20.25%.
Return on Equity (ROE) | -50.69% |
Return on Assets (ROA) | -17.13% |
Return on Capital (ROIC) | -20.25% |
Revenue Per Employee | $393,141 |
Profits Per Employee | -$119,231 |
Employee Count | 516 |
Asset Turnover | 0.90 |
Inventory Turnover | 1.08 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.53% in the last 52 weeks. The beta is 0.24, so TMCI's price volatility has been lower than the market average.
Beta (5Y) | 0.24 |
52-Week Price Change | -6.53% |
50-Day Moving Average | 5.88 |
200-Day Moving Average | 8.11 |
Relative Strength Index (RSI) | 70.36 |
Average Volume (20 Days) | 780,482 |
Short Selling Information
The latest short interest is 4.94 million, so 7.94% of the outstanding shares have been sold short.
Short Interest | 4.94M |
Short Previous Month | 4.91M |
Short % of Shares Out | 7.94% |
Short % of Float | 10.83% |
Short Ratio (days to cover) | 12.74 |
Income Statement
In the last 12 months, TMCI had revenue of $202.86 million and -$61.52 million in losses. Loss per share was -$0.99.
Revenue | 202.86M |
Gross Profit | 163.53M |
Operating Income | -62.10M |
Pretax Income | -63.68M |
Net Income | -61.52M |
EBITDA | -54.63M |
EBIT | -62.10M |
Loss Per Share | -$0.99 |
Full Income Statement Balance Sheet
The company has $82.80 million in cash and $70.12 million in debt, giving a net cash position of $12.68 million or $0.20 per share.
Cash & Cash Equivalents | 82.80M |
Total Debt | 70.12M |
Net Cash | 12.68M |
Net Cash Per Share | $0.20 |
Equity (Book Value) | 104.91M |
Book Value Per Share | 1.68 |
Working Capital | 119.34M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$32.43 million and capital expenditures -$10.77 million, giving a free cash flow of -$43.20 million.
Operating Cash Flow | -32.43M |
Capital Expenditures | -10.77M |
Free Cash Flow | -43.20M |
FCF Per Share | -$0.69 |
Full Cash Flow Statement Margins
Gross margin is 80.61%, with operating and profit margins of -30.61% and -30.33%.
Gross Margin | 80.61% |
Operating Margin | -30.61% |
Pretax Margin | -30.33% |
Profit Margin | -30.33% |
EBITDA Margin | -26.93% |
EBIT Margin | -30.61% |
FCF Margin | -20.91% |
Dividends & Yields
TMCI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -4.46% |
Shareholder Yield | -4.46% |
Earnings Yield | -12.39% |
FCF Yield | -8.70% |
Analyst Forecast
The average price target for TMCI is $7.40, which is -6.80% lower than the current price. The consensus rating is "Hold".
Price Target | $7.40 |
Price Target Difference | -6.80% |
Analyst Consensus | Hold |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 14.29% |
EPS Growth Forecast (5Y) | -20.71% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TMCI has an Altman Z-Score of 2.66 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.66 |
Piotroski F-Score | 2 |